I am a dedicated hematologist who is passionate about understanding the mechanisms that govern somatic clonal mosaicism within the hematopoietic stem cell compartment and the factors that govern progression into overt myeloid neoplasms. I do firmly believe that a better understanding of these mechanisms can lead to a shift in treatment paradigms: prevention of deadly hematological cancers.

I am excited to connect with like-minded professionals, collaborate on cutting-edge research, and contribute to the advancement of hematology and oncology. Let's connect and explore opportunities to make a meaningful impact on patient care and the future of cancer treatment.